Liquid Biopsy Equipment For Medical Diagnostics
-
Manufactured by Bioceptbased in USA
Combining Biocept’s Liquid Biopsy biomarker testing expertise with Oncomine™ from Thermo Fisher Scientific’s next-generation sequencing and decision support ...
-
Manufactured by IMB Dx, Inc.based in SOUTH KOREA
Cell-free DNA (cfDNA) is circulating fragments of DNA that is released from cells into the circulatory system throughout the body. Tumor cells also release DNA into the blood stream, which is called circulation-tumor DNA(ctDNA). IMBdx Inc.’s AlphaLiquid® platform offers industry-leading ctDNA-based precision diagnostics solutions across the full continuum of cancer care, from therapy ...
-
Manufactured by MDxHealthbased in USA
SelectMDx Helps Physicians Determine if a Patient is at Higher or Lower Risk for Prostate Cancer and Which Men Can Safely Avoid Biopsy. A non-invasive urine test (“liquid biopsy”), SelectMDx measures the expression of two mRNA cancer-related biomarkers (HOXC6 and DLX1).1 The test provides binary results that, when combined with the patient’s clinical risk factors, help the ...
-
Manufactured by Omnia Biotechbased in SWEDEN
RNAPro•SAL™ was developed as an easy to use and cost effective tool for the split sample collection of rich sources of RNA miRNA, mRNA and proteins found in saliva. The proprietary RNAPro•SAL™ kit provides two equivalent samples of saliva which total 1.0 mL of saliva in 1-3 minutes. These may be analyzed later for either RNA or protein components. A unique built in Sample ...
-
Manufactured by Anchor Molecularbased in USA
The Extraction Sensitivity Controls can help by monitoring plasma cfDNA loss, determining how low the absolute plasma cfDNA number of copies can be reliably extracted, and standardizing QC workflow for plasma cfDNA extraction process. Two extraction sensitivity panels and two extraction low positive controls are currently available as catalog products. Also, the customized panels and controls can ...
-
Manufactured by Norgen Biotek Corp.based in CANADA
The Small RNA Library Prep Kit for Illumina consists of all the reagents and components required to generate small RNA libraries to be used for next-generation sequencing on an Illumina platform. All molecular reagents including adaptors, primers, enzyme mixes and buffers are provided. A purification module is also provided for rapid purification of nucleic acid products generated at various ...
-
Manufactured by Nanostics Inc.based in CANADA
Our core technology ClarityDX® can: Identify biomarkers expressed by diseased cells/tissues. Indicate if treatment is needed. Predict treatment response and resistance. Stratify disease stage. Identify disease ...
-
Manufactured by Tethis S.p.Abased in ITALY
We internally produce functionalized glass slides with our proprietary nanomaterial deposition technology for unique biological features. SBS slides allow immediate, gentle and efficient adhesion of any living cell, enabling a total capture approach to liquid ...
-
based in GERMANY
MiRNAs are small, highly conserved, non-coding RNAs playing crucial roles in the regulation of virtually all aspects of living ...
-
Manufactured by Streck, Inc.based in USA
Cell-Free DNA BCT is a direct-draw venous whole blood collection device intended for the collection, stabilization and transport of venous whole blood samples for use in conjunction with cell-free DNA next generation sequencing liquid biopsy assays that have been cleared or approved for use with samples collected in the Cell-Free DNA BCT ...
-
Manufactured by Datar Cancer Geneticsbased in UNITED KINGDOM
CancertrackTM is a non-invasive blood based investigation that detects cancer derived biomarkers with ultra-high precision, specificity and reliability. CancertrackTM can be used to monitor the disease /recurrence or changes in the tumor characteristics, as often as necessary, without the cost, risk and consequences of radiation from scans, hospitalisation, anaesthesia or painful surgical ...
-
Manufactured by Creatv MicroTech, Inc.based in USA
Personalized Cancer Therapy and Disease Monitoring: “Liquid biopsy” using circulating tumor cells (CTCs) is potentially a minimally invasive alternative to traditional tissue biopsy to determine cancer therapy. Enumeration of CTCs may be used to indicate prognosis and to monitor treatment. Isolation of CTCs by size exclusion is a widely researched technique to collect CTCs from ...
-
Manufactured by IMB Dx, Inc.based in SOUTH KOREA
AlphaLiquid® Detect is an industry-first tumor-informed, hybrid-capture NGS-based liquid biopsy test designed for MRD detection and recurrence monitoring in stage I-III solid tumor patients. The assay incorporates a personalized panel of up to 1,000 targets, including both tumor-informed patient-specific markers as well as additional therapeutic targets. By delivering exceptional detection ...
-
Manufactured by OncoDNA S.A.based in BELGIUM
OncoSELECT: Smart liquid biopsy panels with selected key genes per tumor type. The Liquid Biopsy Solution For Disease Monitoring Or Therapeutic Decision. OncoSELECT is a fast and minimally invasive analysis of circulating tumor DNA from a blood sample for lung (NSCLC), colorectal and breast (HR+ or HER2+) cancer patients. It is the perfect solution to identify therapeutic options for cancer ...
-
Manufactured by Therawisbased in GERMANY
Oncosome.HER2 is a liquid biopsy diagnostic for the detection of HER2 in blood to identify patients eligible for HER2 targeted therapy. Oncosome.HER2 would address an high unmet medical ...
-
based in UNITED KINGDOM
Oncimmune’s proprietary biomarker discovery engine, which is leveraged in our ImmunoINSIGHTS services to discover and validate novel biomarkers that can help stratify patients in multiple cancer indications and with different autoimmune ...
-
Manufactured by Kailos Genetics, LLC.based in USA
Kailos Iota combines TargetRich, our foundational genetic enrichment technology, with next-generation sequencing and statistical machine learning that results in a highly specific cancer assay of multiple solid tumors at all stages. The Iota assay detects methylation differences in a person’s blood sample, the superior choice for early disease detection. The process of detecting these ...
-
Manufactured by Exosome Diagnostics, Inc.based in USA
The ExoDx Prostate is a simple, non-invasive urine test that can discriminate the risk of aggressive prostate cancer (defined as Gleason Score ≥7). This test is now available as an At-Home Collection Kit that can be initiated by an electronic order signed by the physician and sent directly to the patient’s home for ...
-
Manufactured by Bioceptbased in USA
Combining Biocept’s Liquid Biopsy biomarker testing expertise with Oncomine™ from Thermo Fisher Scientific’s next-generation sequencing and decision support ...
-
Manufactured by Panagene Inc.based in SOUTH KOREA
Lung cancer is a metastatic cancer which the cancer cells are developed in the bronchial tubes or alveoli and grow along the blood vessel or lymphatic vessel. There are two types of lung cancer based on the sizes and shape of the cancer cell; non-small cell lung cancer (NSCLC) takes 75% and small cell lung cancer takes 25%. Usually, it is hard to find lung cancer in the early stage and is ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you